AARD

NASDAQ · Pharmaceuticals

Aardvark Therapeutics Inc

Stocks Under $10 Pharmaceutical Stocks Healthcare Stocks

$5.44

-0.16 (-2.86%)

As of May 9, 9:42 PM ET ·

Analyst Consensus

Buy

Analysts

High

Coverage

Buy 13 72%

Hold 5 28%

Sell 0 0%

Price Target

Analyst Price Target +382.4% upside

Low Target $21.03

Average Target $26.24

High Target $41.18

Current Price $5.44

Current
$5.44

Target
$26.24

$21.03 $26.24 avg $41.18

Scenario Analysis

Bear Case

$21.03

286.6%

Low target

Base Case

$26.24

+382.4%

Avg target

Bull Case

$41.18

+657.0%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$17.94

-69.7% from high

52-Week Low

$3.35

+62.4% from low

Target vs 52W High

$26.24

+46.3% vs high

Next Earnings Report

May 20, 2026

until earnings

EPS Est: $-0.89

Earnings in 9 days. Analyst targets may shift significantly after the report.

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
RDY Dr. Reddy's Laboratories	Hold	45	51%	—	+0.0%
LLY Eli Lilly and Co.	Strong Buy	39	77%	$1,330.33	+40.3%
JNJ Johnson & Johnson	Buy	32	63%	$299.55	+35.3%
MRK Merck & Co. Inc.	Buy	35	71%	$159.27	+43.0%
PFE Pfizer Inc.	Hold	36	44%	$33.90	+32.0%
BMY Bristol-Myers Squibb Co	Hold	36	42%	$174.50	+210.7%
ZTS Zoetis Inc	Buy	25	60%	$209.87	+153.4%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-28.6%